Applicant, as named in the Orange Book

Glenmark Speclt

Next listed expiry: Ryaltris on 21 Nov 2044. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Ryaltris mometasone furoate; olopatadine hydrochloride	mometasone furoate; olopatadine hydrochloride	211746	21 Nov 2044	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.